Molecular & Cellular Toxicology

The Korean Society of Toxicogenomics and Toxicoproteomics (대한독성유전 단백체학회)
권호 표지

Identification of Marker Genes Related to Cardiovascular Toxicity of Doxorubicin and Daunorubicin in Human Umbilical Vein Endothelial Cells (HUVECs)

  • Kim, Youn-Jung (Cellular and Molecular Toxicology Laboratory, Korea Institute of Science & Technology) ;
  • Lee, Ha-Eun (Cellular and Molecular Toxicology Laboratory, Korea Institute of Science & Technology) ;
  • Ryu, Jae-Chun (Cellular and Molecular Toxicology Laboratory, Korea Institute of Science & Technology)
  • Published : 2007.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Doxorubicin and daunorubicin are excellent chemotherapeutic agents utilized for several types of cancer but the irreversible cardiac damage is the major limitation for its use. The biochemical mechanisms of doxorubicin- and daunorubicin- induced cardiotoxicity remain unclear. There are many reports on toxicity of doxorubicin and doxorubicin in cardiomyocytes, but effects in cardiovascular system by these drugs are almost not reported. In this study, we investigated gene expression profiles in human umbilical vein endothelial cells (HUVECs) to better understand the causes of doxorubicin and doxorubicininduced cardiovascular toxicity and to identify differentially expressed genes (DEGs). Through the clustering analysis of gene expression profiles, we identified 124 up-regulated common genes and 298 down-regulated common genes changed by more than 1.5-fold by all two cardiac toxicants. HUVECs responded to doxorubicin and doxorubicin damage by increasing levels of apoptosis, oxidative stress, EGF and lipid metabolism related genes. By clustering analysis, we identified some genes as potential markers on apoptosis effects of doxorubicin and doxorubicin. Six genes of these, BBC3, APLP1, FAS, TP53INP, BIRC5 and DAPK were the most significantly affected by doxorubicin and doxorubicin. Thus, this study suggests that these differentially expressed genes may play an important role in the cardiovascular toxic effects and have significant potential as novel biomarkers to doxorubicin and doxorubicin exposure.

Keywords

References

  1. Devalapally, H. et al. Beta-galactoside prodrugs of doxorubicin for application in antibody directed enzy-me prodrug therapy/prodrug monotherapy. Arch Pharm Res 6:723-732 (2007) https://doi.org/10.1007/BF02977634
  2. Mordente, A. et al. Human heart cytosolic reductases and anthracycline cardiotoxicity. IUBMB Life 52:83-88 (2001) https://doi.org/10.1080/15216540252774829
  3. Barry, E. et al. Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management. Expert Opin Pharmacother 8:1039-1058 (2007) https://doi.org/10.1517/14656566.8.8.1039
  4. Singal, P. K. et al. Adriamycin-induced heart failure: mechanism and modulation. Mol Cell Biochem 207: 77-85 (2000) https://doi.org/10.1023/A:1007094214460
  5. Elliott, P. Pathogenesis of cardiotoxicity induced by anthracyclines. Semin Oncol 33(3 suppl 8):S2-S7 (2006)
  6. Lum, H. & Roebuck, K. A. Oxidant stress and endothelial dysfunction. Am J Physiol 280:C719-C741 (2001)
  7. Grant, D. S., Williams, T. L., Zahaczewsky, M. & Dicker, A. P. Comparison of antiangiogenic activities using paclitaxel (Taxol) and docetaxel (Taxotere). Int J Cancer 104:121-129 (2002)
  8. Kalyanaraman, B. et al. Doxorubicin-induced apoptosis: implications in cardiotoxicity. Mol Cell Biochem 234/235:119-124 (2002) https://doi.org/10.1023/A:1015976430790
  9. Ryu, J. C. et al. Promising next generation technology in toxicology-toxicogenomics. Mol Cell Toxicol 1:1-6 (2005)
  10. Kim, Y. J., Chai, Y. G. & Ryu, J. C. Selenoprotein W as molecular target of methylmercury in human neuronal cells is down-regulated by GSH depletion. Biochem Biophys Res Commun 30:1095-1102 (2005)
  11. Kim, Y. J., Kim, M. S. & Ryu, J. C. Genotoxicity and identification of differentially expressed genes of formaldehyde in human Jurkat cells. Mol Cell Toxicol 1:230-236 (2005)
  12. Tang, X., Milyavsky, M., Goldfinger, N. & Rotter, V. Amyloid-beta precursor-like protein APLP1 is a novel p53 transcriptional target gene that augments neuroblastoma cell death upon genotoxic stress. Oncogene in press (2007)
  13. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63 (1983) https://doi.org/10.1016/0022-1759(83)90303-4
  14. Araki, W. & Wurtman, R. J. Increased expression of amyloid precursor protein and amyloid precursor-like protein 2 during trophic factor withdrawal-induced death of neuronal PC12 cells. Brain Res Mol Brain Res 56:169-177 (1998) https://doi.org/10.1016/S0169-328X(98)00050-3
  15. Frei, K. et al. Ex vivo malignant glioma cells are sensitive to Fas (CD95/APO-1) ligand-mediated apoptosis. J Neuroimmunol 87:105-113(1998) https://doi.org/10.1016/S0165-5728(98)00065-4
  16. Wei, J. S. et al. BBC3 mediates fenretinide-induced cell death in neuroblastoma. Oncogene 54:7976-7983 (2005)
  17. Han, J. W. et al. Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals. Proc Natl Acad Sci USA 20:11318-11323 (2001)
  18. Nathalie, C. et al. Fas ligand is localized to membrane raft, where it displays increased cell death-inducin activity. Blood 6:2384-2391 (2006)
  19. Lee, J. H., Lee, J. H., Rho, S. B. & Chun, T. Programmed cell death 6 (PDCD6) protein interacts with death-associated protein kinase 1 (DAPK1): additive effect on apoptosis via caspase-3 dependent pathway. Biotechnol Lett 14:1011-1015 (2005)
  20. Tusher, V. G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116-5121 (2001)